Association of Standardized Liberation Trials and Duration of Venovenous Extracorporeal Membrane Oxygenation in Patients with Acute Respiratory Failure

<b>Rationale:</b> There is a paucity of evidence around strategies to liberate patients from venovenous (VV) extracorporeal membrane oxygenation (ECMO) for acute respiratory failure. <b>Objectives:</b> The primary aim of this study was to determine if adopting standardized liberation trials (SLTs) for VV ECMO is associated with the duration of ECMO. The secondary aim was to identify factors associated with unsafe liberation and the effects of unsafe liberation on mortality to intensive care unit (ICU) discharge. <b>Methods:</b> This was a single-center retrospective cohort study of patients on VV ECMO for severe respiratory failure comparing endpoints between intervention (SLT) and control (no SLT) periods. <b>Results:</b> A total of 262 patients were included in the study, 13% (35 of 262) received SLTs, and 150 patients were decannulated from ECMO. Implementing SLTs was strongly associated with the duration of VV ECMO to first successful liberation trial (hazard ratio [HR], 1.88 [95% confidence interval (CI), 1.16 to 3.06]; <i>P</i> = 0.01) and decannulation (HR, 1.92 [95% CI, 1.0 to 3.06]; <i>P</i> = 0.01) without increasing the frequency of unsafe liberation (21% [5 of 23] with SLTs vs. 19% [24 of 127] without SLTs; odds ratio [OR], 1.19 [95% CI, -0.4 to 3.5]; <i>P</i> = 0.7). Unsafe liberation was strongly associated with ICU mortality (HR, 4.15 [95% CI, 1.24 to 13.9]; <i>P</i> = 0.02). Factors associated with unsafe liberation were respiratory rate (OR, 1.49 per 5 breaths/min increase [95% CI, 1.07 to 2.08]; <i>P</i> = 0.02) and ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (OR, 0.73 per 30 mm Hg increase [95% CI, 0.57 to 0.93]; <i>P</i> = 0.01) immediately before decannulation. <b>Conclusions:</b> Incorporating SLTs was significantly associated with the duration of VV ECMO, without increasing the frequency of unsafe liberation. Unsafe liberation was associated with increased ICU mortality.

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2025-03-05
DOI
https://doi.org/10.1513/annalsats.202412-1252oc
Citations
4
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
2.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Standardized Liberation Trials and Duration of Venovenous Extracorporeal Membrane Oxygenation in Patients with Acute Respiratory Failure

Niall D. Ferguson, Laveena Munshi, Eddy Fan, Ricardo Teijeiro‐Paradis et al.
4 citations
Annals of the American Thoracic Society
Mechanical Circulatory Support Devices
2.70
article

Association of Standardized Liberation Trials and Duration of Venovenous Extracorporeal Membrane Oxygenation in Patients with Acute Respiratory Failure

Niall D. Ferguson, Laveena Munshi, Eddy Fan, Ricardo Teijeiro‐Paradis, Kuan Liu
article en
4 citations

Abstract

<b>Rationale:</b> There is a paucity of evidence around strategies to liberate patients from venovenous (VV) extracorporeal membrane oxygenation (ECMO) for acute respiratory failure. <b>Objectives:</b> The primary aim of this study was to determine if adopting standardized liberation trials (SLTs) for VV ECMO is associated with the duration of ECMO. The secondary aim was to identify factors associated with unsafe liberation and the effects of unsafe liberation on mortality to intensive care unit (ICU) discharge. <b>Methods:</b> This was a single-center retrospective cohort study of patients on VV ECMO for severe respiratory failure comparing endpoints between intervention (SLT) and control (no SLT) periods. <b>Results:</b> A total of 262 patients were included in the study, 13% (35 of 262) received SLTs, and 150 patients were decannulated from ECMO. Implementing SLTs was strongly associated with the duration of VV ECMO to first successful liberation trial (hazard ratio [HR], 1.88 [95% confidence interval (CI), 1.16 to 3.06]; <i>P</i> = 0.01) and decannulation (HR, 1.92 [95% CI, 1.0 to 3.06]; <i>P</i> = 0.01) without increasing the frequency of unsafe liberation (21% [5 of 23] with SLTs vs. 19% [24 of 127] without SLTs; odds ratio [OR], 1.19 [95% CI, -0.4 to 3.5]; <i>P</i> = 0.7). Unsafe liberation was strongly associated with ICU mortality (HR, 4.15 [95% CI, 1.24 to 13.9]; <i>P</i> = 0.02). Factors associated with unsafe liberation were respiratory rate (OR, 1.49 per 5 breaths/min increase [95% CI, 1.07 to 2.08]; <i>P</i> = 0.02) and ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (OR, 0.73 per 30 mm Hg increase [95% CI, 0.57 to 0.93]; <i>P</i> = 0.01) immediately before decannulation. <b>Conclusions:</b> Incorporating SLTs was significantly associated with the duration of VV ECMO, without increasing the frequency of unsafe liberation. Unsafe liberation was associated with increased ICU mortality.

Annals of the American Thoracic SocietyVol. 22(6)
University Health Network (CA), University of Toronto (CA), Toronto General Hospital (CA), Institute of Health Services and Policy Research (CA), Public Health Ontario (CA), Sinai Health System (CA), Toronto General Hospital Research Institute
Good health and well-being
Openalex Percentile: Top 11%
Mechanical Circulatory Support Devices
2.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.